USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Spain
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Germany
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENE EXPRESSION IN MAMMALIAN CELLS
Japan
2014-000118
Filed on 2014-01-06
2014-000118
Filed on 2014-01-06
Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer
US Patent 9,206,245
Filed on 2013-12-20
Filed on 2013-12-20
Brachyury Polypeptides and Methods for Use
US Application 14/138,629
Filed on 2013-12-23
Filed on 2013-12-23
Engineered Antibody Constant Domain Molecules
Australia
2014200215
Filed on 2014-01-14
2014200215
Filed on 2014-01-14
PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS
Australia
2014201936
Filed on 2014-04-04
2014201936
Filed on 2014-04-04
GP100-Specific T Cell Receptors and Related Materials and Methods of Use
US Patent 9,522,948
Filed on 2013-12-13
Filed on 2013-12-13
IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY
Japan
2013-257556
Filed on 2000-05-26
2013-257556
Filed on 2000-05-26
NON-PEPTIDE AGONISTS AND ANTAGONISTS OF ADRENOMEDULLIN AND GASTRIN RELEASING PEPTIDE
US Application 14/103,605
Filed on 2013-12-11
Filed on 2013-12-11